Effect of γ-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene

Javier A. Menendez, Luciano Vellon, Ramon Colomer, Ruth Lupu

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The ω-6 polyunsaturated fatty acid γ-linolenic acid (GLA; 18:3n-6), which is found in several plant oils and is used as an herbal medicine, has antitumor activity in vitro. We examined the effect of GLA on the expression of the Her-2/neu (erbB-2) oncogene, which is involved in development of numerous types of human cancer. Flow cytometric and immunoblotting analyses demonstrated that GLA treatment substantially reduced Her-2/neu protein levels in the Her-2/neu-overexpressing cell lines BT-474, SK-Br3, and MDA-MB-453 (breast cancer), SK-OV3 (ovarian cancer), and NCI-N87 (gastrointestinal tumor derived). GLA exposure led to a dramatic decrease in Her-2/neu promoter activity and a concomitant increase in the levels of polyomavirus enhancer activator 3 (PEA3), a transcriptional repressor of Her-2/neu, in these cell lines. In transient transfection experiments, a Her-2/neu promoter bearing a PEA3 site-mutated sequence was not subject to negative regulation by GLA in Her-2/neu-overexpressing cell lines. Concurrent treatments of Her-2/neu-overexpressing cancer cells with GLA and the anti-Her-2/neu antibody trastuzumab led to synergistic increases in apoptosis and reduced growth and colony formation.

Original languageEnglish (US)
Pages (from-to)1611-1615
Number of pages5
JournalJournal of the National Cancer Institute
Volume97
Issue number21
DOIs
StatePublished - Nov 2 2005
Externally publishedYes

Fingerprint

alpha-Linolenic Acid
Oncogenes
Cell Line
Neoplasms
Plant Oils
Herbal Medicine
Human Development
Unsaturated Fatty Acids
Immunoblotting
Ovarian Neoplasms
Transfection
Apoptosis
Breast Neoplasms
Antibodies
Growth
Proteins
transcription factor PEA3

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Effect of γ-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene. / Menendez, Javier A.; Vellon, Luciano; Colomer, Ramon; Lupu, Ruth.

In: Journal of the National Cancer Institute, Vol. 97, No. 21, 02.11.2005, p. 1611-1615.

Research output: Contribution to journalArticle

Menendez, Javier A. ; Vellon, Luciano ; Colomer, Ramon ; Lupu, Ruth. / Effect of γ-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene. In: Journal of the National Cancer Institute. 2005 ; Vol. 97, No. 21. pp. 1611-1615.
@article{8c80bdbc834c4192ac6b1137e0dbc5be,
title = "Effect of γ-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene",
abstract = "The ω-6 polyunsaturated fatty acid γ-linolenic acid (GLA; 18:3n-6), which is found in several plant oils and is used as an herbal medicine, has antitumor activity in vitro. We examined the effect of GLA on the expression of the Her-2/neu (erbB-2) oncogene, which is involved in development of numerous types of human cancer. Flow cytometric and immunoblotting analyses demonstrated that GLA treatment substantially reduced Her-2/neu protein levels in the Her-2/neu-overexpressing cell lines BT-474, SK-Br3, and MDA-MB-453 (breast cancer), SK-OV3 (ovarian cancer), and NCI-N87 (gastrointestinal tumor derived). GLA exposure led to a dramatic decrease in Her-2/neu promoter activity and a concomitant increase in the levels of polyomavirus enhancer activator 3 (PEA3), a transcriptional repressor of Her-2/neu, in these cell lines. In transient transfection experiments, a Her-2/neu promoter bearing a PEA3 site-mutated sequence was not subject to negative regulation by GLA in Her-2/neu-overexpressing cell lines. Concurrent treatments of Her-2/neu-overexpressing cancer cells with GLA and the anti-Her-2/neu antibody trastuzumab led to synergistic increases in apoptosis and reduced growth and colony formation.",
author = "Menendez, {Javier A.} and Luciano Vellon and Ramon Colomer and Ruth Lupu",
year = "2005",
month = "11",
day = "2",
doi = "10.1093/jnci/dji343",
language = "English (US)",
volume = "97",
pages = "1611--1615",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "21",

}

TY - JOUR

T1 - Effect of γ-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene

AU - Menendez, Javier A.

AU - Vellon, Luciano

AU - Colomer, Ramon

AU - Lupu, Ruth

PY - 2005/11/2

Y1 - 2005/11/2

N2 - The ω-6 polyunsaturated fatty acid γ-linolenic acid (GLA; 18:3n-6), which is found in several plant oils and is used as an herbal medicine, has antitumor activity in vitro. We examined the effect of GLA on the expression of the Her-2/neu (erbB-2) oncogene, which is involved in development of numerous types of human cancer. Flow cytometric and immunoblotting analyses demonstrated that GLA treatment substantially reduced Her-2/neu protein levels in the Her-2/neu-overexpressing cell lines BT-474, SK-Br3, and MDA-MB-453 (breast cancer), SK-OV3 (ovarian cancer), and NCI-N87 (gastrointestinal tumor derived). GLA exposure led to a dramatic decrease in Her-2/neu promoter activity and a concomitant increase in the levels of polyomavirus enhancer activator 3 (PEA3), a transcriptional repressor of Her-2/neu, in these cell lines. In transient transfection experiments, a Her-2/neu promoter bearing a PEA3 site-mutated sequence was not subject to negative regulation by GLA in Her-2/neu-overexpressing cell lines. Concurrent treatments of Her-2/neu-overexpressing cancer cells with GLA and the anti-Her-2/neu antibody trastuzumab led to synergistic increases in apoptosis and reduced growth and colony formation.

AB - The ω-6 polyunsaturated fatty acid γ-linolenic acid (GLA; 18:3n-6), which is found in several plant oils and is used as an herbal medicine, has antitumor activity in vitro. We examined the effect of GLA on the expression of the Her-2/neu (erbB-2) oncogene, which is involved in development of numerous types of human cancer. Flow cytometric and immunoblotting analyses demonstrated that GLA treatment substantially reduced Her-2/neu protein levels in the Her-2/neu-overexpressing cell lines BT-474, SK-Br3, and MDA-MB-453 (breast cancer), SK-OV3 (ovarian cancer), and NCI-N87 (gastrointestinal tumor derived). GLA exposure led to a dramatic decrease in Her-2/neu promoter activity and a concomitant increase in the levels of polyomavirus enhancer activator 3 (PEA3), a transcriptional repressor of Her-2/neu, in these cell lines. In transient transfection experiments, a Her-2/neu promoter bearing a PEA3 site-mutated sequence was not subject to negative regulation by GLA in Her-2/neu-overexpressing cell lines. Concurrent treatments of Her-2/neu-overexpressing cancer cells with GLA and the anti-Her-2/neu antibody trastuzumab led to synergistic increases in apoptosis and reduced growth and colony formation.

UR - http://www.scopus.com/inward/record.url?scp=27944457982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27944457982&partnerID=8YFLogxK

U2 - 10.1093/jnci/dji343

DO - 10.1093/jnci/dji343

M3 - Article

VL - 97

SP - 1611

EP - 1615

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 21

ER -